StonvexLoading…
StonvexStonvexStonvexCore line items from CPNG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $34.53B | $30.27B | $24.38B | $20.58B |
Operating Income | $473.00M | $436.00M | $473.00M | $-112.00M |
Net Income | $208.00M | $154.00M | $1.36B | $-92.00M |
EPS (Diluted) | $0.11 | $0.08 | $0.75 | $-0.05 |
Total Assets | $17.79B | $15.34B | $13.35B | $9.51B |
Total Liabilities | $13.16B | $11.17B | $9.24B | $7.10B |
Cash & Equivalents | $6.32B | $5.88B | $5.24B | $3.51B |
Free Cash Flow OCF − CapEx | $522.00M | $1.01B | $1.76B | $-259.00M |
Shares Outstanding | 1.85B | 1.83B | 1.80B | 1.76B |